Retinal vessel homeostasis ensures normal ocular functions. Consequently, retinal hypovascularization and neovascularization, causing a lack and an excess of vessels, respectively, are hallmarks of human retinal pathology. We provide evidence that ECspecific genetic ablation of either the transcription factor SRF or its cofactors MRTF-A and MRTF-B, but not the SRF cofactors ELK1 or ELK4, cause retinal hypovascularization in the postnatal mouse eye. Inducible, EC-specific deficiency of SRF or MRTF-A/MRTF-B during postnatal angiogenesis impaired endothelial tip cell filopodia protrusion, resulting in incomplete formation of the retinal primary vascular plexus, absence of the deep plexi, and persistence of hyaloid vessels. All of these features are typical of human hypovascularization-related vitreoretinopathies, such as familial exudative vitreoretinopathies including Norrie disease. In contrast, conditional EC deletion of Srf in adult murine vessels elicited intraretinal neovascularization that was reminiscent of the agerelated human pathologies retinal angiomatous proliferation and macular telangiectasia. These results indicate that angiogenic homeostasis is ensured by differential stage-specific functions of SRF target gene products in the developing versus the mature retinal vasculature and suggest that the actin-directed MRTF-SRF signaling axis could serve as a therapeutic target in the treatment of human vascular retinal diseases.
Introduction
Angiogenesis, the extension of preexisting vascular networks by EC proliferation and sprouting, is essential for organ development and organ function in health and disease (1, 2) . Retinal capillary dysfunction, caused by either impaired vascular growth (hypovascularization) or excessive vascularization (hypervascularization or neoangiogenesis), leads to severe visual impairment and, often, blinding ocular diseases. Ocular hypovascularization diseases encompass familial exudative vitreoretinopathy (FEVR), including Norrie disease (ND) (3) . Vessel hyperproliferation, associated with neovascularization (NV), is found in infants with retinopathy of prematurity (ROP) (4) , in diabetic retinopathy (DR) (5) , and in NV age-related macular degeneration (AMD) (6) . NV AMD, which represents approximately 10% of all AMD yet accounts for nearly 90% of all AMD-associated vision losses (6) , displays either choroidal NV or, more rarely, intraretinal NV. The latter is found in the manifestations of retinal angiomatous proliferation (RAP) (7) and macular telangiectasia (MacTel) (8) (9) (10) .
During angiogenesis and EC sprouting, highly polarized ECs, termed tip cells, are positioned at the distal end of vessels. Stalk cells form the sprout base and maintain a continuous, lumenized connection to the existing vessel network (11) . EC sprouting is highly dynamic and requires rapid rearrangements of the actin cytoskeleton (12) . To sense VEGF gradients and other signals, tip cells continuously extend and retract filopodia and constantly compete with stalk cells for the leading position within angiogenic sprouts (13) .
Murine postnatal retinal development offers insight into molecular and cellular mechanisms of angiogenesis. At P0, a ring-shaped vessel exists around the optic nerve head in the central retina, whereas peripheral regions lack vasculature. Angiogenic growth extends the retinal vasculature into the periphery, thereby establishing the 2-dimensional primary vessel plexus. In addition, beginning at approximately P8, perpendicular sprouting from the primary plexus leads to the formation of 2 additional vessel layers in the deeper retina, the deep plexi (14) . Since global inactivation of genes controlling blood vessel morphogenesis often causes embryonic lethality, the development of inducible genetic models is highly important for the characterization of molecular pathways contributing to retinal angiogenesis in postnatal and adult stages (15) .
Serum response factor (SRF) (16) , a ubiquitously expressed transcription factor, regulates target gene expression in cell type-selective and signal-specific fashion upon recruitment of different cofactors (17) . The SRF cofactors of the ternary complex factor family (TCFs; encoded by Elk1, Elk3, and Elk4) (18, 19) enable SRF-mediated induction of immediate-early genes (IEGs) upon Ras/MAPK signaling, whereas myocardin-related transcription factors (MRTFs; encoded by Mrtfa and Mrtfb, also known as Mkl1 and Mkl2, respectively) (20) (21) (22) function as SRF cofactors responsive to Rho signaling and actin dynamics (23, 24) to regulate cytoskeletal genes (17, 25, 26) . SRF binds a conserved target gene cis element, the CArG box [CC(A/T) 6 GG] (17). Tissue-specific deletion of Srf revealed essential requirements for SRF activity in many cell types, including muscle cells, neurons, and ECs (26) . Dynamic rearrangements of the actin cytoskeleton are communicated to the genome by actin-directed cytoplasmic release of MRTF proteins, followed by induced nuclear MRTF-SRF interaction and activation of transcriptional responses (17, 23, 27) . The contributions of SRF and its cofactors to EC function are poorly understood. In cultured ECs, ELK3 participates in transcriptional responses to hypoxia by regulation of HIF-1α protein stability (28, 29) . In vitro cultured ECs revealed a role for SRF in VEGF-mediated angiogenesis, actin polymerization, and EC migration (30) . The effects of VEGF on SRF activity were suggested to require both MAPK/Erk and RhoA signaling. In vivo, EC SRF loss-of-function studies were so far only performed during embryogenesis (31, 32) , revealing a requirement for SRF in embryonic vascularization. Defects in actin polymerization and in EC intercellular junction formation resulted in embryonic death around E14.5 (31, 32) . The genes encoding VEGF-R2 (Kdr; also known as Vegfr2 or Flk1) and VE-cadherin (Cdh5), among others, were identified as SRF target genes stimulated upon VEGF signaling (31) .
To overcome embryonic lethality of previously used genetic models (31, 32) , we used mice expressing the tamoxifen-inducible recombinase CreER T2 under the control of the EC-specific Cdh5 promoter (33), thus permitting temporally controlled deletion of floxed Srf and Mrtf genes in the endothelium. Postnatal EC ablation of either SRF or MRTFs led to severe developmental vessel growth defects, resembling major characteristics of inherited human retinal pathologies such as ROP and FEVR, including ND (3). Interestingly, we found that EC-specific deletion of Srf in adult mice triggered unwarranted intraretinal NV, reminiscent of the human NV AMD subtypes RAP and MacTel (7, 10) , as well as the RAP/MacTel animal model deficient for the VLDL receptor (VLDLR; encoded by Vldlr) (9) . Moreover, our study investigated EC VEGF signaling mechanisms in vitro and identified MRTF-SRF activation downstream of VEGF. Thus, the present findings offer new insight into the molecular and genetic basis of normal and pathological retinal angiogenesis and suggest cytoskeletal dynamics and the MRTF-SRF module as novel target structures for both diagnosis and treatment of human retinal vascular diseases.
Results

Lethality upon induced EC deletion of Srf during embryonic development.
To validate a new genetic model for temporally controlled, induced EC-specific KO of Srf (referred to herein as Srf iECKO ), Cdh5(PAC)-CreER T2 transgenics (33) were bred with mice carrying a floxed Srf allele (Srf flex1 ; ref. 34) . Tamoxifen was applied successively to pregnant females, and embryos were analyzed at E14.5 or E17.5. Genotypes of the obtained embryos were distributed according to Mendelian ratios. Whereas control embryos appeared normal, freshly isolated Srf iECKO embryos showed severe internal hemorrhaging in the head, back, and limb regions (Supplemental Figure  1 , A-H; supplemental material available online with this article; doi:10.1172/JCI64201DS1). E17.5 Srf iECKO embryos were significantly reduced in weight compared with E14.5 Srf iECKO embryos and uninduced controls (Supplemental Figure 1I) . Levels of Srf mRNA and SRF protein in embryonic limb buds isolated from Srf iECKO animals were significantly reduced compared with control littermates (Supplemental Figure 1 , J-L). These timed Srf deletion experiments demonstrated that our novel tamoxifen-inducible, EC-specific genetic system fully reproduced phenotypes during embryogenesis, which were previously reported for noninducible gene targeting using different Cre drivers and independently generated floxed Srf alleles (31, 32) .
Postnatal EC Srf deletion causes impaired retinal angiogenesis. Taking advantage of the tamoxifen-inducible, temporally controlled gene targeting strategy, we chose the retina to study the effects of EC-specific Srf deletion on postnatal angiogenesis. Newborn pups were successively injected with tamoxifen at P1-P4, and vascularization was analyzed on retinal flat-mounts. As early as P6, isolectin B4 (ILB4) staining of the retinal primary plexus showed a significant 29% reduction in the area covered by blood vessels and a significant 35% decrease in the number of branch points in Srf iECKO animals compared with littermate controls (Figure 1 , A-C). Abnormal tip cell morphology was evident in Srf iECKO retinae, with mutant sprouts displaying short shafts as well as fewer and shorter distal filopodia ( Figure 1, A and D-F) . These data suggest an essential role of SRF in postnatal angiogenesis, especially regarding progression of the retinal angiogenic front, which depends upon actin-mediated tip cell filopodial dynamics (11) .
To monitor Cre recombination, we combined the Srf iECKO model with double-fluorescent mTmG Cre reporter alleles (35) , which switch expression from membrane-targeted Tomato protein (red) to GFP (green) upon Cre activation. Newborn mice were injected at P1-P4, and retinal flat-mounts were analyzed at P8 ( Figure 1G ). In the absence of the reporter, no specific signals were detected in either the red or the green channel. In retinae of uninjected Srf flex1/flex1 Cdh5(PAC)-CreER T2 mTmG mice, all retinal cells showed ubiquitous red fluorescence, whereas no specific signal in the green channel was observed. This proved that the system was not leaky, and no unspecific recombination occurred in the absence of tamoxifen. In retinae of tamoxifen-injected Srf flex1/WT Cdh5(PAC)-CreER T2 mTmG control animals, ECs changed their color to green, highlighting efficient Cre recombination in the endothelium and the expected normal vascularization of the retina for age P8. In contrast, vessel outgrowth in tamoxifen-injected Srf flex1/flex1 Cdh5(PAC)-CreER T2 mTmG mice was strongly impaired, as evidenced by the abnormal position of the angiogenic front formed by green fluorescent, recombined ECs ( Figure 1G ).
Development of deep vascular plexi in the retina requires SRF function. Srf iECKO animals at age P10 contained large avascular zones in the peripheral retina (Figure 2A) , indicative of impaired development of the primary plexus until late stages of retinal vascularization. In control littermates, the primary plexus had reached the retinal periphery and started to extend into deeper retinal layers to form the tertiary and secondary capillary networks of the deep plexi ( Figure 2 , A, C, E, and F). In contrast, Srf iECKO animals showed a 29% reduction in retinal area covered by blood vessels ( Figure 2B) . Interestingly, at the angiogenic front, large clusters of tip cells without filopodia formed (referred to as distal microaneurysms), which were never observed in control animals ( Figure 2C ). Abnormal accumulation of ECs within these microaneurysms was evidenced by EM ( Figure 2D ). Despite the abnormal accumulation of ECs within distal microaneurysms, these abnormal vessel structures were covered by pericytes ( Figure 2D ). Additionally, deep plexi were not established in Srf iECKO animals (most likely as a consequence of abnormal sprouting in the primary plexus), which was further evidenced by EM, whereas control retinae revealed normal deep plexi vessel structures (Figure 2, F and G) . Notably, we did not find a reduction in EC proliferation in Srf iECKO retinae compared with controls (data not shown). To quantitate SRF-mediated gene expression, ECs were enriched from retinal tissue of tamoxifen-treated control and Srf iECKO P10 animals, using anti-CD31-coated magnetic beads. mRNA levels of Srf, as well as SRF target genes Kdr, Cdh5, and Actb (also known as β-actin), were significantly decreased in Srf iECKO retinae ( Figure 2H ). Correspondingly, protein levels of SRF and VEGF-R2 in whole retinal tissue were reduced by 60% and 51%, respectively (Figure 2, I and J).
Persistence of vascular defects in Srf iECKO retinae after postnatal deletion of Srf. Postnatal retinal angiogenesis of WT mice reaches completion by P25 (14) . At advanced ages (P15-P31), retinal irregularities remained in Srf iECKO animals: in vivo imaging using confocal scanning laser ophthalmoscopy (SLO), particularly in fluorescence angiography (FLA) mode, revealed persistent distal microaneurysms of different sizes ( Figure 3A) . Additionally, no deep plexi were detectable in FLA recordings in retinae of these older Srf iECKO mice, and no significant leakage of fluorescent dye out of microaneurysms was observed. Distal microaneurysms were visualized at the persistently recessed angiogenic fronts upon ILB4 staining of retinal flat-mounts, performed after completion of the in vivo imaging ( Figure 3B ). Further vascular abnormalities in Srf iECKO retinae were found in H&E stainings of ocular paraffin sections. Srf iECKO retinae displayed distal microaneurysms positioned aberrantly in the inner nuclear layer (INL; Figure 3C ). Prior to histological preparation, the identical, persistent abnormal blood vessels were detected in vivo via optical coherence tomography (OCT; Figure 3C ). The punctate double reflectance patterns typical of vessels (dark zones at the top and bottom of each vessel) were clearly visible. 
SRF deficiency leads to defective hyaloid vessel regression.
The presence of avascular zones in the periphery o Srf iECKO retinae led us to test whether hyaloid vessels persist, as this vessel system, normally regressing during postnatal development, is known to be retained when the vascular network is compromised (36) . Interestingly, in 64% (7 of 11) of Srf iECKO retinae, persisting hyaloid vessels were seen on flat-mounts ( Figure 4A ). With the exception of 1 of the 10 animals analyzed, no hyaloid vessels were detected on control retinal flat-mounts ( Figure 4A ). Retinal flat-mounts of control animals revealed the existence of all capillary beds and vascularization into the periphery, whereas the presence of hyaloid vessels in Srf iECKO retinae coincided with large avascular zones, microaneurysms, and the absence of deeper capillary beds ( Figure 4A ). In vivo, the course of hyaloid vessels retained in the Srf iECKO retinae could be followed by SLO angiography examining different focal planes of the same eye: hyaloids rose up from their origin at the retinal center and moved toward the back of the lens, then down toward the avascular "target zone" in the periphery ( Figure 4B ). The functional status of these vessels was verified by visible blood flow and pulsations of the whole vessel, as detected by SLO in vivo (data not shown).
Molecular and structural defects in Srf iECKO retinal blood vessels. Retinal blood vessels grow along an underlying astrocytic network, which presents a gradient of matrix-bound VEGF (36) . We analyzed the structure of this astrocytic network by glial fibrillary acidic protein (GFAP) staining of P6 retinal flat-mounts. In both control and Srf iECKO retinae, astrocytes had reached the periphery and formed elaborate networks ( Figure 5A ). Control EC sprouts followed the preceding astrocytic network in close overlap, whereas the overlap between distal vessels and astrocytes was markedly reduced in Srf iECKO retinae ( Figure 5A ). Next, we tested whether the mutant phenotype was caused by sprout retraction and vessel collapse. Both events would generate empty collagen IV sleeves, which are no longer associated with ECs (37, 38). In control retinae, the overlap between EC ILB4 and collagen IV patterns was almost complete ( Figure 5B ). In Srf iECKO flat-mounts, we focused on the distal microaneurysms at the angiogenic front, which revealed a complete absence of empty collagen sleeves ( Figure 5B), indicating that retraction of sprouts or vessels was not the reason for the observed vascular defects.
SRF deficiency in neurons of the forebrain resulted in increased Ser3 phosphorylation of the actin-severing protein cofilin (39) . To analyze whether this indicator of imbalance in actin dynamics was also evident in SRF-deficient retinal ECs, we performed phosphorylated cofilin (P-cofilin) staining on retinal flat-mounts. Low basal P-cofilin staining was detected on control retinal vessels, which was slightly stronger than the neuronal signal in the ganglion cell layer underneath ( Figure 5C ). In contrast, strong P-cofilin staining was found in distal microaneurysms of Srf iECKO mutants ( Figure 5C ). In addition, we observed an increased P-cofilin signal in whole retinal tissue ( Figure 5, D 
and E).
Adult Srf iECKO eyes display retinal NV reminiscent of the Vldlr -/-phenotype. To examine whether SRF plays a role in the maintenance of the fully established mature retinal vasculature of adult mice, Srf deletion was induced at 4-6 weeks of age, well after the completion of all developmental growth and maturation processes. Resulting ocular phenotypes were analyzed by SLO, OCT, and staining on paraffin sections. Covering a time span of 3-26 weeks after adultstage tamoxifen injection, 82% of Srf iECKO animals (n = 11) displayed multiple ectopic intraretinal NVs that were not observed in control littermates, as shown by in vivo SLO followed by H&E staining after paraffin sectioning ( Figure 6, A-D) . The abnormal NV structures were further characterized in OCT ( Figure 6A ). Collectively, these analyses revealed that NV retinal capillaries originated from deep plexi and connected to the retinal pigment epithelium (RPE). At the site of connection, RPE cells appeared to engulf the NV. Additionally, local distortion of outer nuclear layer (ONL) and INL layering was evident in Srf iECKO retinae ( Figure 6D ). We confirmed the intraretinal origin and endothelial nature of the NV lesions by ILB4 fluorescence staining ( Figure 6E ). Thus, formation of intraretinal NV clearly indicated that SRF function is critically required to maintain endothelial homeostasis of a healthy adult retinal vasculature.
The observed NV phenotype in adult Srf iECKO retinae was highly reminiscent of that previously seen in Vldlr -/-retinae (9, 40-43), which also display intraretinal NV that is associated with photoreceptor degeneration. We therefore used 6-to 8-month-old Srf iECKO and control littermates to analyze in further detail signs of retinal degeneration. Similar to Vldlr -/-retinae (9), we found multiple NV lesions with rupture of the RPE, RPE cells surrounding the NV site, mislayering and cell displacement within the INL and ONL, and thinning of the ONL in Srf iECKO animals ( Figure 7A ). Semiquantitative RT-PCR of whole retinal tissue for cone-specific expression of Opn1 (encoding opsin-1) and rod-specific expression of Rho (encoding rhodopsin), which are related to photoreceptor viability and health (9), revealed a significant 23% decrease in levels of both mRNAs in Srf iECKO mice ( Figure 7B ). However, the mRNA level of Vegfa was unchanged in our model ( Figure 7B ), consistent with our earlier demonstration by in vivo SLO imaging of perfused, intact, and nonleaky blood vessels ( Figure 6 , B and C). In an attempt to uncover potential cellular mechanisms underlying the NV phenotype, we used an in vitro approach, downregulating SRF by siRNA in cultured immortalized mouse ECs (mECs) (44) . Western blotting confirmed that SRF protein was downregulated after transfection of mECs with siRNA against Srf (Figure 7, C and  D) . The obtained decrease in Srf mRNA correlated with a decrease in the SRF target gene Actb, as assayed by semiquantitative RT-PCR. Cfl1 (encoding cofilin) -which was previously found not to be under SRF transcriptional control, but rather posttranslational control (39) -was expectedly unchanged at the mRNA level ( Figure 7E ). However, most interestingly, mRNA expression of Thbs1 (encoding the VLDLR ligand thrombospondin-1) was significantly decreased in SRF-depleted mECs ( Figure 7E ). The thrombospondin promoter contains a perfect SRF-binding CArGbox of CCTTATTTGG sequence at promoter coordinate -1.2 kb (45) . Using ChIP, we showed that SRF bound to this element in the Thbs1 gene; Pak1, a CArG box-negative locus, served as normalization control, and Actb served as positive reference ( Figure 7F ). Taken together, these results demonstrated that EC-specific ablation of SRF in the adult retinal endothelium leads to NV lesions associated with reduced photoreceptor viability. The congruence of this phenotype with Vldlr -/-mice, together with our finding that the VLDLR ligand thrombospondin-1 was under transcriptional control of SRF in mECs, suggests that impairment of the antiproliferative VLDLR-thrombospondin pathway contributes to formation of intraretinal NV lesions in adult Srf iECKO retinae.
MRTF, but not TCF, cofactors are essential for retinal angiogenesis. To identify cofactors recruited by SRF in mediating retinal vascular development, we performed KO studies on 4 of the 5 known genes encoding TCFs and MRTFs. We first took advantage of a newly generated, constitutive Elk1 -/-Elk4 -/-double-KO mouse model (46) . In the retinal vasculature, radial outgrowth was found to be unaffected in P6 and P10 Elk1 -/-Elk4 -/-versus controls, which included Elk1 -/-Elk4 +/+ and Elk1 -/-Elk4 +/-genotypes (Figure 8, A , B, D, and E). The angiogenic front of Elk1 -/-Elk4 -/-retinae at P6 appeared normal: tip cells extended numerous filopodia indistinguishable from those of controls ( Figure 8C ). Moreover, deep plexi were visible in both control and Elk1 -/-Elk4 -/-retinae at P10 (Figure 8, F and G). SRF and P-cofilin protein levels were unchanged in Elk1 -/-Elk4 -/-retinae (Supplemental Figure 2B) . These data demonstrated that the TCF-type SRF cofactors ELK1 and ELK4 were not required for vascularization of the retina.
To determine whether the SRF cofactors MRTF-A and MRTF-B play a role in SRF-dependent retinal angiogenesis instead, we generated mice with Cre-inducible EC-specific KO of MRTF-B on a constitutive Mrtfa-KO background (referred to herein as Mrtfa -/-Mrtfb iECKO mice). Mrtfa -/-Mrtfb iECKO mice showed retinal blood vessel defects highly reminiscent of those of Srf iECKO mice. This congruency in phenotype with Srf iECKO mice was evidenced by the Mrtfa -/-
Figure 4
Impaired regression of hyaloid vessels in Srf iECKO retinae. (A) ILB4 staining on retinal flat-mounts of P17 control and Srf iECKO retinae, displayed at lower (left; composite images, see Methods) and higher (middle and right) magnification. Flat-mount preparation used conditions to preserve hyaloid vessels. Red arrow indicates retarded angiogenic front; white arrows indicate persistent hyaloid vessels in Srf iECKO retinae. In the central area (middle), all capillary beds and no hyaloids were demonstrated in control retinae, whereas in Srf iECKO retinae, deep plexi were absent, but hyaloids were present. In the periphery (right), control retinae demonstrated complete vascularization, whereas outer avascular zones remained in Srf iECKO retinae, displaying distal microaneurysms and hyaloid vessels. (B) SLO angiography of Srf iECKO eyes revealed the course of hyaloid vessels, from their origin at the retinal center toward the avascular "target zone" in the periphery, via tracing on 3 different focal planes of the same eye (right, retinal surface; middle, intermediate level; left, just below the lens). Arrowheads denote hyaloid vessels, arrow denotes retinal vessel. Scale bars: 1 mm (A, left); 100 μm (A, middle and right).
Mrtfb iECKO animals' reductions in radial outgrowth at P6 and P10, number of branching points, formation of abnormal sprouts at P6, and formation of distal microaneurysms as well as by their absence of deep plexi at P10 (Figure 9 , A-D and G-J). The reductions in filopodial number and length were comparable in Mrtfa -/-Mrtfb iECKO retinae ( Figure 9 , E and F) and in Srf iECKO retinae. Importantly, in Mrtfa -/-Mrtfb iECKO retinae, SRF protein levels were unchanged, whereas P-cofilin was markedly increased (Supplemental Figure 2,  A and B) . KO of Mrtfa and Mrtfb individually caused partial impairment of angiogenic front progression in each genotype. Detailed analysis of radial outgrowth in P8 retinae suggested a gene-dosage effect: radial outgrowth decreased successively with decreasing WT allele composition for Mrtfa and Mrtfb ( Figure  9K and Supplemental Figure 3 ). Taken together, the highly overlapping phenotypic characteristics of Mrtfa -/-Mrtfb iECKO and Srf iECKO mice were strongly suggestive of MRTFs being the relevant EC SRF cofactors in vivo ensuring appropriate retinal angiogenesis.
VEGF-A induces cytoplasm-to-nucleus translocation of MRTF-A and SRF target gene expression.
The above genetic evidence for essential contributions of SRF and MRTF to retinal angiogenesis led us to investigate signaling cascades activating SRF in mECs. Interestingly, both serum and VEGF-A treatment of mECs activated MRTF-A to translocate from the cytoplasm to the nucleus ( Figure 10A ). The sensitivity of this effect to latrunculin B ( Figure 10A ) suggested involvement of G-actin in retaining MRTF-A within the cytoplasm (24) . Similarly, cytochalasin D and jasplakinolide, 2 F-actin-modulating substances known to liberate MRTF from G-actin (24, 27), induced nuclear MRTF-A translocation in mECs (Supplemental Figure 4) . To further probe into the functionality of VEGF-induced MRTF activation, we used luciferase-based transient reporter gene assays, which harbored promoter sequences that either did [(TSm) 2 ] or did not [(Tmm) 2 ] contain an intact SRF binding site ( Figure 10B ). In transfected human retinal microvascular ECs (HRMECs), VEGF-stimulated (TSm) 2 reporter activity was enhanced by cotransfected MRTF expression vectors, an effect that was dependent on the presence of intact SRF binding sites ( Figure 10C ). Finally, VEGF-A treatment of mECs increased mRNA levels of the endogenous SRF target genes Flt1 (also known as Vegfr1), Kdr, Srf, Actb, and Fos (Figure 10D) . These results argue for VEGF-induced cooperation of SRF and MRTF in ECs that leads to expression of essential proangiogenic genes. We therefore propose that VEGF-induced MRTF translocation to the nucleus activates in ECs expression of SRF target genes with cytoskeletal functions, which in turn is essential for motile activities of tip cells to ensure appropriate vascularization of the postnatal retina ( Figure 10E ).
Discussion
The genetic study presented here identifies the murine transcription factor SRF to be essential for EC function, both during postnatal development of the retinal vasculature and in maintenance of adult capillary homeostasis. Most importantly, whereas EC-specific SRF ablation at postnatal stages caused hypovascularization of the primary plexus and the absence of deep retinal plexi, EC depletion of SRF at adult stages led to intraretinal NV. Both of these opposing murine phenotypes, elicited upon stage-specific SRF depletion, resembled blinding human retinopathies, i.e., developmental hypovascularization found in early-onset FEVR (including ND) (3, 47) versus the adult-onset intraretinal NV AMD subtypes RAP and MacTel (7, 8) .
Alterations of retinal vessels were the earliest phenotypic effects we detected upon induction of postnatal or adult EC-specific SRF depletion. However, besides the retinal phenotype, we observed some behavioral abnormalities. We attribute these behavioral effects to compromised functions of cerebral microvessels, which do not appear to exert influences on the retinal phenotype described here and will be characterized separately.
Postnatal defects in retinal development upon EC-specific Srf deletion included retarded progression of the angiogenic front and impaired tip cell filopodial protrusion, which generated avascular zones and distal microaneurysms in the primary plexus and, consequently, a complete absence of deep plexi. This was associated with persistence of the hyaloid vasculature. EC-specific depletion of the SRF cofactors MRTF-A/MRTF-B, but not ELK1/ELK4, led to similar phenotypes with respect to postnatal retinal vascularization, thereby providing clear genetic evidence for an essential functional interaction of SRF and MRTFs in directing EC activities. Since actin dynamics provide a driving force for such motility functions, including tip cell filopodial activity (11, 12) , our observation that VEGF-A signaling elicited actin-dependent translocation of cytoplasmic MRTF into the nucleus represents a new molecular mechanism by which angiogenic signals induce motile functions of ECs.
The phenotype upon postnatal ablation of MRTF-SRF signaling described herein showed strong similarities to human pathologies and murine model systems of FEVR, including ND (47, 48) . Since identified genetic lesions eliciting FEVR and ND fall into the Wnt signaling pathway, including mutant alleles for Ndp, Fzd4, Lrp5, and Tspan12 (3), our data suggest the existence of cross-talk between Wnt and actin signaling in guaranteeing proper EC function during retinal angiogenesis.
In contrast to postnatal SRF depletion, Srf deletion in adult ECs elicited intraretinal NV. This phenotype was characterized by neoangiogenic activities originating from intraretinal deep capillaries and causing non-uniformly distributed focal lesions. The latter displayed distortions in INL and ONL layering, local thinning of the ONL, disruption of photoreceptors associated with reduced expression of Opn1 and Rho, and rupture of the RPE with RPE cells enveloping the NV structures. Collectively, these abnormalities represent characteristic features of the human NV AMD subtypes RAP (7) and MacTel (8) (9) (10) . Very similar phenotypic features were displayed by mice deficient for VLDLR, a component of reelin signaling exerting inhibitory effects on EC proliferation (9, 40-43). In addition to binding reelin, VLDLR also binds the ligand thrombospondin-1 (49, 50) . The glycoprotein thrombos- pondin is an extracellular matrix component known to inhibit EC proliferation (51, 52) . Interestingly, the THBS1 gene has been previously suggested to be under transcriptional control of SRF in human fibroblasts (45) . Using siRNA and ChIP approaches, we here provided evidence suggesting Thbs1 expression is under control of SRF in cultured mECs (Figure 7) . We therefore hypothesize that SRF-controlled expression of thrombospondin is required in adult retinal vessels to inhibit pathological EC proliferation, thereby providing an explanation for both the NV phenotype we observed upon adult-stage SRF depletion and the overlapping phenotypic characteristics with the MacTel model of Vldlr -/-mice. As shown in the Vldlr -/-model, constitutive VLDLR deficiency did not severely affect postnatal development of the primary plexus, but rather caused abnormal intraretinal vessel growth during deep plexi formation (9) , which suggests that VLDLR functions in maintaining homeostasis of primarily deep retinal vessels. Our phenotype of intraretinal NV upon adult SRF depletion and the hypothesized impairment of VLDLR signaling by associated thrombospondin deficiency are fully consistent with the defects displayed by Vldlr -/-mice.
Both RAP and MacTel show age-dependent onset in human patients. Since SRF activities are known to deteriorate in some aging cells (53) , it will be of great interest to explore potential contributions of age-dependent SRF activity changes in the aging retinal endothelium of human AMD patients. Furthermore, our work might suggest modulation of EC SRF activity, as well as elevation of thrombospondin activity, as therapeutic options for the treatment of some NV AMD pathologies, such as RAP and MacTel.
The MRTF/SRF transcriptional feedback circuit, which links cytoplasmic actin polymerization with nuclear gene regulation, represents one of the best-understood mechanisms for genomic sensing of cytoskeletal dynamics (24, 27) . Associated cellular functions include dynamic changes regarding cell polarity, cell shape, migration, and guided growth, all of which are essential to EC biology. Mechanistically, our conclusion that VEGF-A signaling activates G-actin-dependent MRTF-A translocation from the cytoplasm to the nucleus ( Figure 10E ) positions the MRTF-SRF module at the center of angiogenic regulation.
In conclusion, our genetic study using conditional depletion of SRF and MRTFs provides the first in vivo identification of any function for these transcription factors in the retinal endothelium of living animals. The phenotypic defects we describe in postnatal and adult retinal angiogenesis provide new insight into both the molecular developmental biology of retinal angiogenesis and the etiology of selected retinal pathologies. The findings reported here may help to define therapeutic approaches for the treatment of some human diseases related to abnormal retinal vascularization. double-fluorescent reporter (35) were crossed into the Srf flex1 Cdh5(PAC)-CreER T2 background. Genotyping was performed by PCR of tail biopsies (see Supplemental Table 1 for primer sequences).
Tamoxifen injections. For embryonic Cre activation, timed pregnant females were injected intraperitoneally on E10.5, E12.5, and E14.5 with 2 mg tamoxifen (dissolved in sunflower oil), and embryos were analyzed on E17.5. In a second series of experiments, females were injected on E10.5, E11.5, and E12.5, and embryos were analyzed on E14.5. For postnatal Cre activation, newborn pups were injected intragastrically on P1-P4 with 0.05 mg tamoxifen and analyzed on P6, P8, and P10 and at advanced age (P15-P31). For adult analysis, 4-to 6-week-old mice were injected intra peritoneally with 2 mg tamoxifen on 5 consecutive days and analyzed at different time points, ranging from 3 to 26 weeks after the last injection.
Antibody staining of retinal flat-mounts. Eyes were isolated and fixed in 4% PFA for 2 hours (54). After washing 2× for 5 minutes with PBS, retinae were dissected and incubated in blocking buffer (1% BSA, 0.3% Triton-X, and PBS) overnight at 4°C. After washing 3× for 5 minutes with PBS, retinae were treated 3× for 20 minutes with Pblec buffer (1 mM CaCl2, 1 mM MgCl2, 0.1 mM MnCl2, 1% Triton-X, and PBS, pH 6.8). Incubation with primary antibodies was done at 4°C in Pblec buffer overnight. After washing 3× for 20 minutes with half blocking solution (0.5% BSA, 0.15% Triton-X, and PBS), retinae were incubated with secondary antibodies (2 hours at room temperature). After washing 3× for 20 minutes in half blocking solution, retinae were flat-mounted on coverslides and embedded in Mowiol.
Primary antibodies were as follows: ILB4 from Griffonia simplificolia (1:25 dilution; Sigma-Aldrich); GFAP (1:100 dilution; DAKO); collagen IV (1:40 dilution; AbD Serotec); P-cofilin (1:100 dilution; Cell Signaling). Secondary antibodies (all from Molecular Probes) were as follows: streptavidinAlexa Fluor 488 (1:100 dilution), anti-rabbit Alexa Fluor 546 (1:200 dilution), anti-rat Alexa Fluor 546 (1:200 dilution).
Analysis of morphometric parameters of retinal flat-mounts. Radial outgrowth was determined as the ratio of blood vessel-covered retinal area to total retinal area, and expressed as a percentage. VEGF-A. Pretreatment with latrunculin B was for 30 minutes. (TSm)2 and (Tmm)2 reporter plasmids (in which "m" denotes a mutated binding site) contained 2 tandem copies of the c-Fos serum response element (SRE) upstream of the thymidine kinase basal promoter sequence (-120 to +1), able to drive luciferase cDNA expression. The WT SRE contains binding sites for the transcription factors TCF, SRF, and AP-1. For transfection of siRNAs directed against Srf (siSRF797; Purimex) (60), mECs were seeded into 6-cm dishes with penicillin/streptomycin-free medium 1 day before transfection. For transfection (RNAiMAX reagent; Invitrogen) with 166 pmol siRNA per dish, cells had reached approximately 60% confluence. Transfection was stopped after 5 hours, and RNA was isolated 2 days later. Extracts for protein analysis were generated 2 and 3 days after transfection.
ChIP. For ChIP analysis (61), mECs were serum starved for 18 hours before stimulation with 15% FCS for 1 hour. See Supplemental Table 1 for primer sequences and amplification protocols. Anti-SRF ChIP signals of CArG boxes in Actb and Thbs1 were normalized to either IgG-containing or no-antibody control reactions and expressed relative to Pak1 (CArG boxnegative control locus).
EM. For EM, retinae were fixed 4 hours in 2.5% glutaraldehyde (Paesel + Lorei GmbH) in 0.1 M cacodylate buffer (CB; pH 7.4). Specimens were washed in pure CB, postfixed in 1% OsO4 in CB for 1 hour, dehydrated in ascending series of ethanol and propyleneoxide, bloc-stained in uranyl acetate for 4 hours, and flat-embedded in Araldite (Serva). An ultramicrotome (Ultracut; Leica) was used to cut semithin (1 μm) and ultrathin (50 nm) sections. Ultrathin sections were stained with lead citrate, mounted on copper grids, and analyzed with a Zeiss EM 10 electron microscope (Zeiss). Pictures were scanned at 300 dpi and processed (Adobe Photoshop).
Microscopy. Fluorescent staining analysis used inverse Zeiss Axiovert 200 M microscopes with AxioCam MRm camera and ApoTome (Zeiss), using AxioVision graphics software. Retinal overviews (original magnification, ×5) are presented as composite images of individual, successively overlapping (5%) images, generated by computer-controlled x-y settings and processed using MosaiX Software. H&E-stained sections were visualized using Zeiss Axioplan 2 with AxioCamHRc camera. Higher magnifications were obtained with ×10, ×20, ×40, and ×63 objectives. Statistics. Data are presented as mean ± SEM. For comparisons between experiments, values were normalized to control (assigned as 1 or 100%). 2-tailed Student's t tests were used to identify statistical significance. Statistical significance was assumed for P values less than 0.05.
Study approval. All animal experiments were approved by the Regierungspräsidium Tübingen (Tübingen, Germany).
